SE7702462L - Nya pyridinforeningar - Google Patents

Nya pyridinforeningar

Info

Publication number
SE7702462L
SE7702462L SE7702462A SE7702462A SE7702462L SE 7702462 L SE7702462 L SE 7702462L SE 7702462 A SE7702462 A SE 7702462A SE 7702462 A SE7702462 A SE 7702462A SE 7702462 L SE7702462 L SE 7702462L
Authority
SE
Sweden
Prior art keywords
pyridyl
associations
formula
new pyridine
compounds
Prior art date
Application number
SE7702462A
Other languages
English (en)
Other versions
SE430062B (sv
Inventor
J P E Carlsson
R E A V Axen
H N Y Drevin
G E S Lindgren
Original Assignee
Pharmacia Fine Chemicals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Fine Chemicals Ab filed Critical Pharmacia Fine Chemicals Ab
Priority to SE7702462A priority Critical patent/SE430062B/sv
Priority to DE19782808523 priority patent/DE2808523A1/de
Priority to US05/882,546 priority patent/US4149003A/en
Priority to GB8456/78A priority patent/GB1597756A/en
Priority to FR7806161A priority patent/FR2382450A1/fr
Priority to JP2406678A priority patent/JPS53130674A/ja
Publication of SE7702462L publication Critical patent/SE7702462L/sv
Publication of SE430062B publication Critical patent/SE430062B/sv
Priority to JP60290918A priority patent/JPS61191675A/ja

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • C07D213/71Sulfur atoms to which a second hetero atom is attached
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyamides (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7702462A 1977-03-04 1977-03-04 Kopplings- eller tioleringsreagens SE430062B (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE7702462A SE430062B (sv) 1977-03-04 1977-03-04 Kopplings- eller tioleringsreagens
DE19782808523 DE2808523A1 (de) 1977-03-04 1978-02-28 Neue pyridinverbindungen sowie deren verwendung
US05/882,546 US4149003A (en) 1977-03-04 1978-03-02 Pyridine disulfide compounds
GB8456/78A GB1597756A (en) 1977-03-04 1978-03-03 Pyridine disulphide derivatives and their use as bifunctional coupling agents and as thiolating agents
FR7806161A FR2382450A1 (fr) 1977-03-04 1978-03-03 Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols
JP2406678A JPS53130674A (en) 1977-03-04 1978-03-04 Novel pyridine compound
JP60290918A JPS61191675A (ja) 1977-03-04 1985-12-25 巨大分子物質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7702462A SE430062B (sv) 1977-03-04 1977-03-04 Kopplings- eller tioleringsreagens

Publications (2)

Publication Number Publication Date
SE7702462L true SE7702462L (sv) 1978-09-05
SE430062B SE430062B (sv) 1983-10-17

Family

ID=20330623

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7702462A SE430062B (sv) 1977-03-04 1977-03-04 Kopplings- eller tioleringsreagens

Country Status (6)

Country Link
US (1) US4149003A (sv)
JP (2) JPS53130674A (sv)
DE (1) DE2808523A1 (sv)
FR (1) FR2382450A1 (sv)
GB (1) GB1597756A (sv)
SE (1) SE430062B (sv)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
SE446184B (sv) * 1979-01-12 1986-08-18 Toyo Jozo Kk Polyfunktionell disulfidforening anvendbar som tverbindande medel
SE8003732L (sv) * 1980-05-19 1981-11-20 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
US4563304A (en) * 1981-02-27 1986-01-07 Pharmacia Fine Chemicals Ab Pyridine compounds modifying proteins, polypeptides or polysaccharides
SE8102194L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
SE8102193L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och dess anvendning
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
FR2522269A1 (fr) * 1982-02-26 1983-09-02 Pasteur Institut Agents antitumoraux, tels que la daunorubicine, a efficacite amelioree, leur obtention et procede pour augmenter l'efficacite des agents antitumoraux
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
US4614712A (en) * 1983-02-25 1986-09-30 The Upjohn Company Immunoassays with luciferase labeled ligands or receptors
SE8302758L (sv) * 1983-05-17 1984-11-18 Pharmacia Ab Sett for uppspjelkning av disulfidbindningar och derigenom erhallen forening
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
DE3587845T2 (de) * 1984-12-03 1994-10-20 Hoechst Celanese Corp Verfahren zur Bestimmung eines Liganden.
US4797491A (en) * 1986-03-17 1989-01-10 Cetus Corporation Compound 1-(3-(2-pyridyldithio)propionamido)-12-(5-hydrazidoglutaramido)-4,9-dioxadodecane
US4880935A (en) * 1986-07-11 1989-11-14 Icrf (Patents) Limited Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
JPS6391563A (ja) * 1986-10-07 1988-04-22 Nitsusui Seiyaku Kk 細菌由来蛋白特異抗原の検査法
US4798795A (en) * 1987-02-17 1989-01-17 Hoechst Celanese Corporation Biotinylating agents
US4709037A (en) * 1987-02-17 1987-11-24 Hoechst Celanese Corporation Biotinylating agents
US4794082A (en) * 1987-02-17 1988-12-27 Hoechst Celanese Corporation Biotinylating agents
JPS63189278U (sv) * 1987-05-28 1988-12-05
DE3809986A1 (de) * 1988-03-24 1989-10-05 Boehringer Mannheim Gmbh Verbindungen zur einfuehrung einer sh-gruppe in tyrosin
JPH0253770U (sv) * 1988-10-12 1990-04-18
JP2619549B2 (ja) * 1989-06-29 1997-06-11 日本商事株式会社 抗原の定量法およびそれに用いる固相
US5137877B1 (en) * 1990-05-14 1996-01-30 Bristol Myers Squibb Co Bifunctional linking compounds conjugates and methods for their production
WO1992001938A1 (en) * 1990-07-20 1992-02-06 City Of Hope Derivatization of c-terminal proline
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
US20030176512A1 (en) * 1998-08-11 2003-09-18 Kirkpatrick D. Lynn Asymmetric disulfides and methods of using same
US6552060B1 (en) 1997-08-11 2003-04-22 Prolx Pharmaceuticals, Inc. Asymmetric disulfides and methods of using same
AR030612A1 (es) * 2000-09-12 2003-08-27 Smithkline Beecham Corp Procedimiento e intermedios
AU2003259163B2 (en) * 2002-08-16 2008-07-03 Immunogen, Inc. Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
WO2004037310A2 (en) 2002-10-21 2004-05-06 Allvivo, Inc. Surface coating comprising bioactive compound
US7858108B2 (en) 2003-10-21 2010-12-28 Richard Nagler Elutable surface coating
KR100984459B1 (ko) * 2004-07-02 2010-09-29 제넨테크, 인크. Iap의 억제제
NZ555601A (en) 2004-12-09 2009-07-31 Centocor Inc Anti-integrin immunoconjugates, methods and uses
JP5007235B2 (ja) 2004-12-20 2012-08-22 ジェネンテック, インコーポレイテッド Iapのピロリジンインヒビター
EP1853322B1 (en) * 2005-02-11 2014-06-25 ImmunoGen, Inc. Process for preparing maytansinoid antibody conjugates
US20110166319A1 (en) * 2005-02-11 2011-07-07 Immunogen, Inc. Process for preparing purified drug conjugates
AU2006283726C1 (en) * 2005-08-24 2015-05-07 Immunogen, Inc. Process for preparing maytansinoid antibody conjugates
NZ594746A (en) * 2005-12-19 2013-03-28 Genentech Inc Inhibitors of iap
US20070260041A1 (en) * 2006-05-03 2007-11-08 David Crich Allylic disulfide rearrangement and desulfurization method for the preparation of allylic sulfides
RU2466131C2 (ru) * 2006-12-19 2012-11-10 Дженентек, Инк. Имидазопиридиновые ингибиторы iap
US8907092B2 (en) * 2007-04-30 2014-12-09 Genentech, Inc. Inhibitors of IAP
US20110046066A1 (en) * 2008-01-11 2011-02-24 Genentech, Inc. Inhibitors of iap
CN102171209A (zh) 2008-08-02 2011-08-31 健泰科生物技术公司 Iap抑制剂
SG10201810743WA (en) 2009-06-03 2018-12-28 Immunogen Inc Conjugation methods
SI2691155T1 (sl) 2011-03-29 2019-03-29 Immunogen, Inc. Priprava majtanzinoidnih konjugatov protiteles v postopku z enim korakom
SG10201702737TA (en) 2012-10-04 2017-05-30 Immunogen Inc Use of a pvdf membrane to purify cell-binding agent cytotoxic agent conjugates
WO2014210267A1 (en) 2013-06-28 2014-12-31 Immunogen, Inc. Purification of intermediates used in the preparation of heterobifunctional linkers
KR102325753B1 (ko) 2019-12-20 2021-11-11 주식회사 포스코 흑색 도금 강판 및 그 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872450A (en) * 1955-12-06 1959-02-03 Bayer Ag Thio- and dithio-carboxylic acid esters and a process for their manufacture
US3950348A (en) * 1971-12-30 1976-04-13 Merck & Co., Inc. Process for preparing e-pyridyl-4-methyloxycarbonyllysine

Also Published As

Publication number Publication date
JPS6121227B2 (sv) 1986-05-26
SE430062B (sv) 1983-10-17
JPS53130674A (en) 1978-11-14
GB1597756A (en) 1981-09-09
DE2808523A1 (de) 1978-09-07
JPS61191675A (ja) 1986-08-26
FR2382450A1 (fr) 1978-09-29
DE2808523C2 (sv) 1987-11-19
JPS624368B2 (sv) 1987-01-30
US4149003A (en) 1979-04-10
FR2382450B1 (sv) 1982-11-05

Similar Documents

Publication Publication Date Title
SE7702462L (sv) Nya pyridinforeningar
SE7702463L (sv) Reaktivt derivat av en sh-grupphaltig polymer
SE7903327L (sv) Cykloalkyltriazoler och forfarande for erhallande av desamma
SE8105240L (sv) Teofyllin- och teobrominderivat
AU2058283A (en) 2-amino-3-acylamino-6-benzylamino pyridine derivatives
AU534361B2 (en) Processes
SE7710873L (sv) Nya 1h-pyrazolo(3,4-b)pyridiner
FI854577A (fi) Kefalosporiner.
SE8405123L (sv) Forfarande for framstellning av pyrrolidin- eller pyridinkarboxylsyraderivat
OA07767A (fr) Procédé de préparation de composés de cephème.
GB1527807A (en) Thiazolines
SE7901510L (sv) Halogensubstituerade merkaptoacylaminosyror
SE7608608L (sv) Forfarande for framstellning av nya diamino-androstaner
DK316589A (da) Substituerede azacyclohexylderivater af rifamyciner
ATE18044T1 (de) Substituierte thiazolidinylester von mineralsaeuren.
DK392579A (da) Fremgangsmaade til fremstilling af 4,5-methano-bufadienolid-rhamnosider
ES469896A1 (es) Procedimiento para la obtencion de derivados de la hidroxi-4tiazolinationa-2
SE7812371L (sv) Forfarande for framstellning av fenoxialkanolaminderivat
SE8107021L (sv) Nytt forfarande for framstellning av imidazo(4,5-b)-pyridiner och -pyrimidiner
ATE26268T1 (de) 2-alkoxyaminosulfonylbenzolsulfonyl-harnstoffderivate.
SE7811761L (sv) 4,5,6,7-tetrahydroimidazo-(4,5-c),pyridinderivat och forfarande for deras framstellning
ES501137A0 (es) Un procedimiento de preparacion de derivados de tiazol
SE8107551L (sv) 1,2-dihydro-5-(pyridinyl)nikotinamidderivat och forfarande for framstellning derav
GB1513631A (en) Piperidine derivatives
SE8204331L (sv) Forfarande for framstellning av 6-(3,6-dihydro-1-(2h)-pyridyl)pyrimidin-3-oxider

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7702462-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7702462-8

Format of ref document f/p: F